tirzepatide regulatory filings https://investor.lilly.com/news-releases/news-release-details/zepbound- tirzepatide-most-prescribed-weight-management “Eli Lilly and Company (NYSE: LLY) today announced the U.S. Food and Drug Administration (FDA) approved a label expansion for Zepbound tirzepatide regulatory filings BPI Labs

barbarum , or goji berries in combination with health, diseases, and safety

The topical drug, which is applied directly to inflamed skin, is now being tested in a multicenter clinical trial in patients with eczema

Strother says youll likely feel hungrier again within about a week

Clinical research has also examined methylcobalamin for neuropathic pain conditions

Less hunger keeps you from overeating at your next meal, reducing your overall calorie intake

New commentary from American Association of Clinical Endocrinology (AACE) president Scott Isaacs, MD, FACP, FACE, examines the full SURPASS-CVOT dataset published in NEJM Group and shares his thoughts on what the findings mean for cardiometabolic care in patients with type 2 diabetes and established ASCVD